Palvella Therapeutics (PVLA) Misses Q1 EPS by 120c

Palvella Therapeutics (NASDAQ: PVLA) reported Q1 EPS of ($1.20).

For earnings history and earnings-related data on Palvella Therapeutics (PVLA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00